TABLE 5.
Antibiotic resistance in pathogens isolated from CSF of patients in the case group
| Antibiotics | Total number | Resistant number | Resistant rate (%) |
|---|---|---|---|
| Aztreonam | 8 | 8 | 100.00 |
| Cefazolin | 11 | 11 | 100.00 |
| Benzylpenicillin | 1 | 1 | 100.00 |
| Cefuroxime | 11 | 10 | 90.91 |
| Penicillin | 48 | 43 | 89.58 |
| Ampicillin | 12 | 10 | 83.33 |
| Ampicillin/sulbactam | 11 | 9 | 81.82 |
| Ceftriaxone | 11 | 9 | 81.82 |
| Erythromycin | 50 | 37 | 74.00 |
| Biapenem | 7 | 5 | 71.43 |
| Cefotetan | 11 | 7 | 63.64 |
| Cefepime | 11 | 7 | 63.64 |
| Piperacillin | 11 | 7 | 63.64 |
| Cefoxitin | 48 | 30 | 62.50 |
| Clindamycin | 49 | 27 | 55.10 |
| Meropenem | 11 | 6 | 54.55 |
| Imipenem | 11 | 6 | 54.55 |
| Ceftazidime | 11 | 5 | 45.45 |
| Tobramycin | 11 | 5 | 45.45 |
| Piperacillin/tazobactam | 11 | 5 | 45.45 |
| Ciprofloxacin | 60 | 26 | 43.33 |
| Levofloxacin | 58 | 25 | 43.10 |
| Cefoperazone/sulbactam | 10 | 4 | 40.00 |
| Polymyxin B | 3 | 1 | 33.33 |
| Tetracycline | 49 | 15 | 30.61 |
| Gentamicin | 60 | 16 | 26.67 |
| Moxifloxacin | 49 | 10 | 20.41 |
| Amikacin | 11 | 2 | 18.18 |
| Nitrofurantoin | 59 | 7 | 11.86 |
| Rifampicin | 48 | 3 | 6.25 |
| Vancomycin | 49 | 1 | 2.04 |
| Tigecycline | 54 | 1 | 1.85 |
| Linezolid | 49 | 0 | 0.00 |
| Minocycline | 2 | 0 | 0.00 |